BRAF and melanoma: AC>TT, AC>CT, CA>TT, and CA>AT mutations can activate the BRAF oncogene in melanomas; however, data showing the induction of AC or CA photoproducts (Figure 1) is limited (Su et al., 2010), and even less is known about the frequency or context of such lesions.